Date: May 6-7, 2025
Location: The Hyatt Regency, Boston, Massachusetts
Details: Panitch Schwarze attorneys Travis W. Bliss, Ph.D., Erin M. Dunston, Philip L. Hirschhorn, and Stephany G. Small, Ph.D. will discuss life sciences patent considerations during the 7th Annual Life Sciences Patent Network (LSPN) North America–Spring Conference, an event co-sponsored by the firm.
During roundtable sessions, Hirschhorn and Dunston will discuss post-grant reviews, and Bliss and Small will discuss the latest challenges in antibody patents.
Bliss will moderate a discussion titled “Best Practices: Post-Grant Proceedings in the U.S. and EPO.” Dunston will be a panelist alongside Emily Hayes of Mewburn Ellis. Participants will provide an overview of recent happenings regarding patent procedures at the United States Patent and Trademark Office (USPTO) and the European Patent Organisation (EPO). They will also cover important considerations for navigating defensive and offensive strategies.
Bliss assists clients throughout the entire IP process, from strategy development, counseling, and opinions; to procurement of appropriate IP rights; to monetization of those assets; and, finally, to enforcing IP rights through litigations in court and before the USPTO.
Dunston focuses her practice on patent procurement, opinions, enforcement (both in district courts and before the Patent Trial and Appeal Board), and portfolio strategy.
Hirschhorn is an experienced trial lawyer specializing in patent litigation and other intellectual property proceedings, including post-grant proceedings before the Patent Trial and Appeals Board of the USPTO.
Small focuses her practice on acquiring and preserving intellectual property rights in all areas of life science, including biologics, pharmaceuticals, treatment/diagnostic methods, novel plant varieties, and transgenic plants.
Organized by Life Sciences Intellectual Property Review, LSPN North America Spring 2025 gathers professionals from the intricate world of life sciences IP. Participants share cutting-edge insights into IP challenges in the pharmaceutical, biotechnology, and medical technology industries.
Click here to register for LSPN North America Spring 2025.